• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

构建并探究肺腺癌中缺氧和干性特征相关 lncRNA 联合 ceRNA 调控网络

Construction and investigation of a combined hypoxia and stemness index lncRNA-associated ceRNA regulatory network in lung adenocarcinoma.

机构信息

Department of Medical Oncology, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, No. 1 Beiguandajie, Tongzhou District, Beijing, 101149, China.

Department of Cellular and Molecular Biology, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, 101149, China.

出版信息

BMC Med Genomics. 2020 Nov 4;13(1):166. doi: 10.1186/s12920-020-00816-8.

DOI:10.1186/s12920-020-00816-8
PMID:33148251
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7643392/
Abstract

Hypoxia and stemness are important factors in tumor progression. We aimed to explore the ncRNA classifier associated with hypoxia and stemness in lung adenocarcinoma (LUAD). We found that the prognosis of LUAD patients with high hypoxia and stemness index was worse than that of patients with low hypoxia and stemness index. RNA expression profiles of these two clusters were analyzed, and 6867 differentially expressed (DE) mRNAs were screened. Functional analysis showed that DE mRNAs were associated with cell cycle and DNA replication. Protein-protein interaction network analysis revealed 20 hub genes, among which CENPF, BUB1, BUB1B, KIF23 and TTK had significant influence on prognosis. In addition, 807 DE lncRNAs and 243 DE miRNAs were identified. CeRNA network analysis indicated that AC079160.1-miR-539-5p-CENPF may be an important regulatory axis that potentially regulates the progression of LUAD. The expression of AC079160.1 and CENPF were positively correlated with hypoxia and stemness index, while miR-539-5p expression level was negatively correlated with hypoxia and stemness index. Overall, we identified CENPF, BUB1, BUB1B, KIF23 and TTK as potentially key genes involved in regulating hypoxia-induced tumor cell stemness, and found that AC079160.1-miR-539-5p-CENPF axis may be involved in regulating hypoxia induced tumor cell stemness in LUAD.

摘要

缺氧和干性是肿瘤进展的重要因素。我们旨在探索与肺腺癌(LUAD)缺氧和干性相关的非编码 RNA 分类器。我们发现,具有高缺氧和干性指数的 LUAD 患者的预后比具有低缺氧和干性指数的患者差。分析了这两个聚类的 RNA 表达谱,筛选出 6867 个差异表达(DE)mRNA。功能分析表明,DE mRNAs 与细胞周期和 DNA 复制有关。蛋白质-蛋白质相互作用网络分析揭示了 20 个枢纽基因,其中 CENPF、BUB1、BUB1B、KIF23 和 TTK 对预后有显著影响。此外,还鉴定出 807 个 DE lncRNAs 和 243 个 DE miRNAs。CeRNA 网络分析表明,AC079160.1-miR-539-5p-CENPF 可能是一个重要的调控轴,可能调节 LUAD 的进展。AC079160.1 和 CENPF 的表达与缺氧和干性指数呈正相关,而 miR-539-5p 的表达水平与缺氧和干性指数呈负相关。总的来说,我们确定了 CENPF、BUB1、BUB1B、KIF23 和 TTK 作为潜在的关键基因,参与调节缺氧诱导的肿瘤细胞干性,并发现 AC079160.1-miR-539-5p-CENPF 轴可能参与调节 LUAD 中缺氧诱导的肿瘤细胞干性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2655/7643392/0d1dc380126e/12920_2020_816_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2655/7643392/c3e2442a9338/12920_2020_816_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2655/7643392/6acbac517507/12920_2020_816_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2655/7643392/e0bec560ea2d/12920_2020_816_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2655/7643392/0e13cdbe3ad6/12920_2020_816_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2655/7643392/62b3d9a69a57/12920_2020_816_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2655/7643392/a2e42d4fe5a5/12920_2020_816_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2655/7643392/22cd55807272/12920_2020_816_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2655/7643392/23fdc6b37c02/12920_2020_816_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2655/7643392/0d1dc380126e/12920_2020_816_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2655/7643392/c3e2442a9338/12920_2020_816_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2655/7643392/6acbac517507/12920_2020_816_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2655/7643392/e0bec560ea2d/12920_2020_816_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2655/7643392/0e13cdbe3ad6/12920_2020_816_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2655/7643392/62b3d9a69a57/12920_2020_816_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2655/7643392/a2e42d4fe5a5/12920_2020_816_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2655/7643392/22cd55807272/12920_2020_816_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2655/7643392/23fdc6b37c02/12920_2020_816_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2655/7643392/0d1dc380126e/12920_2020_816_Fig9_HTML.jpg

相似文献

1
Construction and investigation of a combined hypoxia and stemness index lncRNA-associated ceRNA regulatory network in lung adenocarcinoma.构建并探究肺腺癌中缺氧和干性特征相关 lncRNA 联合 ceRNA 调控网络
BMC Med Genomics. 2020 Nov 4;13(1):166. doi: 10.1186/s12920-020-00816-8.
2
Identification of a Novel Cancer Stemness-Associated ceRNA Axis in Lung Adenocarcinoma via Stemness Indices Analysis.通过干细胞指标分析鉴定肺腺癌中新型癌症干性相关 ceRNA 轴。
Oncol Res. 2021 Sep 7;28(7):715-729. doi: 10.3727/096504020X16037124605559. Epub 2020 Oct 26.
3
Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.预测涉及人肺腺癌进展的失调竞争内源性 RNA 特征。
Cancer Biomark. 2020;29(3):399-416. doi: 10.3233/CBM-200133.
4
Characterization of a non-coding RNA-associated ceRNA network in metastatic lung adenocarcinoma.转移性肺腺癌中 ncRNA 相关 ceRNA 网络的表征。
J Cell Mol Med. 2020 Oct;24(20):11680-11690. doi: 10.1111/jcmm.15778. Epub 2020 Aug 29.
5
Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.三种新型竞争性内源性 RNA 生物标志物在肺腺癌中具有预后价值的综合分析。
Biomed Res Int. 2020 Aug 4;2020:2837906. doi: 10.1155/2020/2837906. eCollection 2020.
6
A comprehensive study of construction and analysis of competitive endogenous RNA networks in lung adenocarcinoma.肺腺癌中竞争性内源性 RNA 网络的构建与分析的综合研究。
Biochim Biophys Acta Proteins Proteom. 2020 Aug;1868(8):140444. doi: 10.1016/j.bbapap.2020.140444. Epub 2020 May 11.
7
Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.基于异常 lncRNA-miRNA-mRNA 网络和 Cox 回归模型的肺腺癌预后生物标志物的综合分析。
Biosci Rep. 2020 Jan 31;40(1). doi: 10.1042/BSR20191554.
8
Construction and Analysis of Survival-Associated Competing Endogenous RNA Network in Lung Adenocarcinoma.构建并分析肺腺癌中与生存相关的竞争性内源性 RNA 网络。
Biomed Res Int. 2021 Feb 11;2021:4093426. doi: 10.1155/2021/4093426. eCollection 2021.
9
Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.肺腺癌和肺鳞癌中异常表达的 lncRNAs 和 miRNAs 谱的综合分析及其相关 ceRNA 网络。
Pathol Oncol Res. 2020 Jul;26(3):1935-1945. doi: 10.1007/s12253-019-00780-4. Epub 2020 Jan 2.
10
Distinct Patterns of mRNA and lncRNA Expression Differences Between Lung Squamous Cell Carcinoma and Adenocarcinoma.肺鳞癌和腺癌之间 mRNA 和长链非编码 RNA 表达差异的独特模式。
J Comput Biol. 2020 Jul;27(7):1067-1078. doi: 10.1089/cmb.2019.0164. Epub 2019 Nov 22.

引用本文的文献

1
Characterization of the immune cell infiltration patterns in lung adenocarcinoma to facilitate immunotherapy.肺腺癌中免疫细胞浸润模式的特征分析以促进免疫治疗。
Heliyon. 2025 Feb 15;11(4):e42720. doi: 10.1016/j.heliyon.2025.e42720. eCollection 2025 Feb 28.
2
Targeting Kinesins for Therapeutic Exploitation of Chromosomal Instability in Lung Cancer.靶向驱动蛋白以治疗性利用肺癌中的染色体不稳定
Cancers (Basel). 2025 Feb 18;17(4):685. doi: 10.3390/cancers17040685.
3
Investigating combined hypoxia and stemness indices for prognostic transcripts in gastric cancer: Machine learning and network analysis approaches.

本文引用的文献

1
MicroRNA-374b-5p Functions as a Tumor Suppressor in Non-Small Cell Lung Cancer by Targeting FOXP1 and Predicts Prognosis of Cancer Patients.微小RNA-374b-5p通过靶向FOXP1在非小细胞肺癌中发挥肿瘤抑制作用并预测癌症患者的预后。
Onco Targets Ther. 2020 May 15;13:4229-4237. doi: 10.2147/OTT.S243221. eCollection 2020.
2
KRT8 and KRT19, associated with EMT, are hypomethylated and overexpressed in lung adenocarcinoma and link to unfavorable prognosis.KRT8 和 KRT19 与 EMT 相关,在肺腺癌中呈低甲基化和过表达,与不良预后相关。
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20193468.
3
Proteins and Molecular Pathways Relevant for the Malignant Properties of Tumor-Initiating Pancreatic Cancer Cells.
探究胃癌预后转录本的低氧和干性联合指数:机器学习与网络分析方法
Biochem Biophys Rep. 2024 Dec 19;41:101897. doi: 10.1016/j.bbrep.2024.101897. eCollection 2025 Mar.
4
Integration of single-cell sequencing and bulk transcriptome data develops prognostic markers based on PCLAF stem-like tumor cells using artificial neural network in gastric cancer.整合单细胞测序和批量转录组数据,利用人工神经网络在胃癌中基于PCLAF干细胞样肿瘤细胞开发预后标志物。
Heliyon. 2024 Sep 29;10(21):e38662. doi: 10.1016/j.heliyon.2024.e38662. eCollection 2024 Nov 15.
5
Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies.BUB1 检查点激酶的表达是癌症治疗反应的预测因子。
Sci Rep. 2024 Feb 23;14(1):4461. doi: 10.1038/s41598-024-55080-y.
6
Stemness genes and miR-1247-3p expression associate with clinicopathological parameters and prognosis in lung adenocarcinoma.干性基因和 miR-1247-3p 的表达与肺腺癌的临床病理参数和预后相关。
PLoS One. 2023 Nov 10;18(11):e0294171. doi: 10.1371/journal.pone.0294171. eCollection 2023.
7
Comprehensive landscape and future perspective of long noncoding RNAs in non-small cell lung cancer: it takes a village.非小细胞肺癌中长链非编码RNA的综合概况与未来展望:众人拾柴火焰高。
Mol Ther. 2023 Dec 6;31(12):3389-3413. doi: 10.1016/j.ymthe.2023.09.015. Epub 2023 Sep 21.
8
The hypoxia-associated genes in immune infiltration and treatment options of lung adenocarcinoma.肺腺癌免疫浸润与治疗选择相关的低氧相关基因。
PeerJ. 2023 Aug 7;11:e15621. doi: 10.7717/peerj.15621. eCollection 2023.
9
Identification and validation of a novel phagocytosis regulators-related signature with potential prognostic and immunotherapeutic value in patients with lung adenocarcinoma.在肺腺癌患者中鉴定并验证一种具有潜在预后和免疫治疗价值的新型吞噬作用调节因子相关特征。
Front Oncol. 2022 Nov 2;12:988332. doi: 10.3389/fonc.2022.988332. eCollection 2022.
10
Identification of a ZC3H12D-regulated competing endogenous RNA network for prognosis of lung adenocarcinoma at single-cell level.单细胞水平鉴定 ZC3H12D 调控的肺腺癌竞争内源性 RNA 网络用于预后判断。
BMC Cancer. 2022 Jan 28;22(1):115. doi: 10.1186/s12885-021-08992-1.
与肿瘤起始胰腺癌细胞恶性特性相关的蛋白质和分子途径。
Cells. 2020 Jun 3;9(6):1397. doi: 10.3390/cells9061397.
4
E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT.E-钙黏蛋白在胰腺导管腺癌中的作用:上皮间质转化中的多面手
Cells. 2020 Apr 22;9(4):1040. doi: 10.3390/cells9041040.
5
Is a Prognosis Signature and Potential Oncogene of Lung Adenocarcinoma.是肺腺癌的预后标志物和潜在致癌基因。
DNA Cell Biol. 2020 May;39(5):890-899. doi: 10.1089/dna.2019.4970. Epub 2020 Apr 13.
6
Prognostic value of epithelial-mesenchymal transition-inducing transcription factors in head and neck squamous cell carcinoma: A meta-analysis.上皮-间质转化诱导转录因子在头颈部鳞状细胞癌中的预后价值:一项荟萃分析。
Head Neck. 2020 May;42(5):1067-1076. doi: 10.1002/hed.26104. Epub 2020 Feb 12.
7
Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer.CENPF的过表达与乳腺癌的不良预后和肿瘤骨转移相关。
Cancer Cell Int. 2019 Oct 11;19:264. doi: 10.1186/s12935-019-0986-8. eCollection 2019.
8
Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells.肿瘤微环境中的缺氧诱导因子作为癌症干细胞的治疗靶点。
Life Sci. 2019 Nov 15;237:116952. doi: 10.1016/j.lfs.2019.116952. Epub 2019 Oct 14.
9
Long non‑coding RNAs in lung cancer: Regulation patterns, biologic function and diagnosis implications (Review).长链非编码 RNA 与肺癌:调控模式、生物学功能及诊断意义(综述)。
Int J Oncol. 2019 Sep;55(3):585-596. doi: 10.3892/ijo.2019.4850. Epub 2019 Jul 29.
10
Lidocaine inhibits proliferation and metastasis of lung cancer cell via regulation of miR-539/EGFR axis.利多卡因通过调控 miR-539/EGFR 轴抑制肺癌细胞的增殖和转移。
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):2866-2874. doi: 10.1080/21691401.2019.1636807.